For a diversion specialist, the first question may be why an event was flagged. For a compliance leader, it may be how the concern was evaluated. A clear record helps both follow the evidence and understand the decision.
Begin with the finding
Record the event identifier, expected medication, concentration, and volume alongside the analytical findings. Distinguish a verified match, a discrepancy, and an inconclusive assessment.
Describe the observation precisely. “Measured concentration below the expected strength” gives the next reviewer more useful information than a general statement that an event failed.
Connect the event with its context
Review available clinician, witness, time, and location information. Compare relevant dispensing, administration, and waste records, including how the expected values were entered or obtained.
For collected waste, include the connection between the original waste event and the sample tested by pharmacy. ASHP’s guidelines emphasize retrievable evidence of custody when controlled substances move between people, including transfers for testing.1
WasteWitness findings are one part of this record. Clinical documentation and the hospital’s review notes supply additional context.
Look for repetition without losing the detail
WasteScore helps administrators see recurring findings across waste events. Cases organize findings that warrant attention, while the Watchlist supports monitoring of emerging or recurring patterns.
Return to the contributing events when reviewing a pattern. Consider the medications, locations, workflow, and available documentation before drawing a conclusion.
Document the review and next action
Use your hospital’s established process to capture:
- Evidence reviewed: Which events, findings, and supporting records informed the assessment.
- Assessment: What was explained and what remains unresolved.
- Follow-up: The action, responsible person, and review date.
- Disposition: Why the concern was closed, monitored, or escalated.
This approach supports internal reviews, compliance audits, and investigations with a traceable account of the work performed. The result informs the review; your team determines the response.
Read the original sources
- ASHP Guidelines on Preventing Diversion of Controlled Substances
Clark J, et al. American Journal of Health-System Pharmacy. 2022;79:2279 - 2306. See Chain of custody, p. 2288.
Read the ASHP guidelines (PDF) (opens in a new tab)
